Literature DB >> 24345279

Correlations between colonic crypt mucin chemotype, inflammatory grade and Desulfovibrio species in ulcerative colitis.

G Lennon1, Á Balfe, N Bambury, A Lavelle, A Maguire, N G Docherty, J C Coffey, D C Winter, K Sheahan, P R O'Connell.   

Abstract

AIM: The colonic mucus gel layer is composed of mucins that may be sulphated or sialyated. Sulphated mucins predominate in health while in ulcerative colitis (UC) sulphation is reduced. These differences result directly from inflammatory events. It may also be hypothesized that they arise in part from alterations in the colonic microbiota, particularly changes in the burden of sulphated mucin-metabolizing species, such as Desulfovibrio (DSV) bacteria. The aim of this study was to correlate colonic mucin chemotypes and inflammatory scores in health and UC and relate these changes to changes in the colonization of colonic crypts by DSV.
METHOD: Paired colonic biopsies from 34 healthy controls (HC) and 19 patients with active UC were collected for the purpose of parallel histological and microbiological assessment. High-iron diamine and Alcian blue staining and haematoxylin and eosin of mucosal biopsy specimens were used to assess histological changes within the clinical spectrum of UC. Quantitative real-time polymerase chain reaction analysis was employed to determine the total and DSV copy number within the colonic crypts.
RESULTS: Compared with HC, the mucin chemotype in UC was less sulphated and inversely correlated with the degree of mucosal inflammation. A weak but significant negative correlation was found between the abundance of sulphated mucins and DSV burden.
CONCLUSION: Mucin composition strongly correlates with the degree of mucosal inflammation, and to a lesser extent with DSV burden. These data suggest that mucin chemotype and DSV burden are linked phenomena and highlight the need to consider changes in mucin chemotype in the setting of microbial dysbiosis occurring within the colitic colon. What does this paper add to the literature? Decreased sulphation of mucins has been associated with inflammation in ulcerative colitis. Currently there are few data describing the relationship between microbial species and changes in mucin chemotype. This study validates previous findings and presents evidence of changes in mucin chemotype occurring in tandem with coherent changes in the microbiota within crypt niches. Colorectal Disease
© 2013 The Association of Coloproctology of Great Britain and Ireland.

Entities:  

Keywords:  Desulfovibrio; Ulcerative colitis; mucin chemotype

Mesh:

Substances:

Year:  2014        PMID: 24345279     DOI: 10.1111/codi.12503

Source DB:  PubMed          Journal:  Colorectal Dis        ISSN: 1462-8910            Impact factor:   3.788


  26 in total

Review 1.  IBD and the gut microbiota--from bench to personalized medicine.

Authors:  Emanuelle Bellaguarda; Eugene B Chang
Journal:  Curr Gastroenterol Rep       Date:  2015-04

2.  Proinflammatory Sulfur-Reducing Bacteria Are More Abundant in Colonic Biopsies of Patients with Microscopic Colitis Compared to Healthy Controls.

Authors:  Valentine Millien; Daniel Rosen; Jason Hou; Rajesh Shah
Journal:  Dig Dis Sci       Date:  2018-10-15       Impact factor: 3.199

3.  Gut microbiota-dependent modulation of innate immunity and lymph node remodeling affects cardiac allograft outcomes.

Authors:  Jonathan S Bromberg; Lauren Hittle; Yanbao Xiong; Vikas Saxena; Eoghan M Smyth; Lushen Li; Tianshu Zhang; Chelsea Wagner; W Florian Fricke; Thomas Simon; Colin C Brinkman; Emmanuel F Mongodin
Journal:  JCI Insight       Date:  2018-10-04

4.  Resistant starch alters gut microbiome and metabolomic profiles concurrent with amelioration of chronic kidney disease in rats.

Authors:  Dorothy A Kieffer; Brian D Piccolo; Nosratola D Vaziri; Shuman Liu; Wei L Lau; Mahyar Khazaeli; Sohrab Nazertehrani; Mary E Moore; Maria L Marco; Roy J Martin; Sean H Adams
Journal:  Am J Physiol Renal Physiol       Date:  2016-02-03

5.  Colonisation of the colonic mucus gel layer with butyrogenic and hydrogenotropic bacteria in health and ulcerative colitis.

Authors:  Helen Earley; Grainne Lennon; J Calvin Coffey; Desmond C Winter; P Ronan O'Connell
Journal:  Sci Rep       Date:  2021-03-31       Impact factor: 4.379

Review 6.  Systematic Review: The Gut Microbiome and Its Potential Clinical Application in Inflammatory Bowel Disease.

Authors:  Laila Aldars-García; María Chaparro; Javier P Gisbert
Journal:  Microorganisms       Date:  2021-04-30

Review 7.  Influences of the colonic microbiome on the mucous gel layer in ulcerative colitis.

Authors:  Gráinne Lennon; Aine Balfe; Helen Earley; Liam A Devane; Aonghus Lavelle; Desmond C Winter; J Calvin Coffey; P Ronan O'Connell
Journal:  Gut Microbes       Date:  2014-04-08

Review 8.  Therapeutic Potential to Modify the Mucus Barrier in Inflammatory Bowel Disease.

Authors:  Jing Sun; Xiao Shen; Yi Li; Zhen Guo; Weiming Zhu; Lugen Zuo; Jie Zhao; Lili Gu; Jianfeng Gong; Jieshou Li
Journal:  Nutrients       Date:  2016-01-14       Impact factor: 5.717

9.  Glucosamine Ameliorates Symptoms of High-Fat Diet-Fed Mice by Reversing Imbalanced Gut Microbiota.

Authors:  Xubing Yuan; Junping Zheng; Lishi Ren; Siming Jiao; Cui Feng; Yuguang Du; Hongtao Liu
Journal:  Front Pharmacol       Date:  2021-06-03       Impact factor: 5.810

Review 10.  Bugs, genes, fatty acids, and serotonin: Unraveling inflammatory bowel disease?

Authors:  Jonathan Kaunitz; Piyush Nayyar
Journal:  F1000Res       Date:  2015-10-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.